1
|
Ahuja CS, Wilson JR, Nori S, Kotter MRN,
Druschel C, Curt A and Fehlings MG: Traumatic spinal cord injury.
Nat Rev Dis Primers. 3(17018)2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Fan B, Wei Z, Yao X, Shi G, Cheng X, Zhou
X, Zhou H, Ning G, Kong X and Feng S: Microenvironment imbalance of
spinal cord injury. Cell Transplant. 27:853–866. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Ahuja CS, Nori S, Tetreault L, Wilson J,
Kwon B, Harrop J, Choi D and Fehlings MG: Traumatic spinal cord
injury-repair and regeneration. Neurosurgery. 80 (3S):S9–S22.
2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Courtine G and Sofroniew MV: Spinal cord
repair: Advances in biology and technology. Nat Med. 25:898–908.
2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Assinck P, Duncan GJ, Hilton BJ, Plemel JR
and Tetzlaff W: Cell transplantation therapy for spinal cord
injury. Nat Neurosci. 20:637–647. 2017.PubMed/NCBI View
Article : Google Scholar
|
6
|
Zhou P, Guan J, Xu P, Zhao J, Zhang C,
Zhang B, Mao Y and Cui W: Cell therapeutic strategies for spinal
cord injury. Adv Wound Care (New Rochelle). 8:585–605.
2019.PubMed/NCBI View Article : Google Scholar
|
7
|
Piltti KM, Funes GM, Avakian SN, Salibian
AA, Huang KI, Carta K, Kamei N, Flanagan LA, Monuki ES, Uchida N,
et al: Increasing human neural stem cell transplantation dose
alters oligodendroglial and neuronal differentiation after spinal
cord injury. Stem Cell Reports. 8:1534–1548. 2017.PubMed/NCBI View Article : Google Scholar
|
8
|
Nicaise AM, Banda E, Guzzo RM, Russomanno
K, Castro-Borrero W, Willis CM, Johnson KM, Lo AC and Crocker SJ:
iPS-derived neural progenitor cells from PPMS patients reveal
defect in myelin injury response. Exp Neurol. 288:114–121.
2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Liu S, Schackel T, Weidner N and
Puttagunta R: Biomaterial-Supported cell transplantation treatments
for spinal cord injury: Challenges and perspectives. Front Cell
Neurosci. 11(430)2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Marquardt LM, Doulames VM, Wang AT, Dubbin
K, Suhar RA, Kratochvil MJ, Medress ZA, Plant GW and Heilshorn SC:
Designer, injectable gels to prevent transplanted Schwann cell loss
during spinal cord injury therapy. Sci Adv.
6(eaaz1039)2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Assunção-Silva RC, Gomes ED, Sousa N,
Silva NA and Salgado AJ: Hydrogels and cell based therapies in
spinal cord injury regeneration. Stem Cells Int.
2015(948040)2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Jessen KR, Mirsky R and Lloyd AC: Schwann
cells: Development and role in nerve repair. Cold Spring Harb
Perspect Biol. 7(a020487)2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Feltri ML, Poitelon Y and Previtali SC:
How Schwann cells sort axons: New concepts. Neuroscientist.
22:252–265. 2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Hill CE, Moon LD, Wood PM and Bunge MB:
Labeled Schwann cell transplantation: Cell loss, host Schwann cell
replacement, and strategies to enhance survival. Glia. 53:338–343.
2006.PubMed/NCBI View Article : Google Scholar
|
15
|
Zhou XH, Ning GZ, Feng SQ, Kong XH, Chen
JT, Zheng YF, Ban DX, Liu T, Li H and Wang P: Transplantation of
autologous activated Schwann cells in the treatment of spinal cord
injury: Six cases, more than five years of follow-up. Cell
Transplant. 21 (Suppl 1):S39–S47. 2012.PubMed/NCBI View Article : Google Scholar
|
16
|
Monje PV, Deng L and Xu XM: Human Schwann
cell transplantation for spinal cord injury: Prospects and
challenges in translational medicine. Front Cell Neurosci.
15(690894)2021.PubMed/NCBI View Article : Google Scholar
|
17
|
Yue K, Trujillo-de Santiago G, Alvarez MM,
Tamayol A, Annabi N and Khademhosseini A: Synthesis, properties,
and biomedical applications of gelatin methacryloyl (GelMA)
hydrogels. Biomaterials. 73:254–271. 2015.PubMed/NCBI View Article : Google Scholar
|
18
|
Khayat A, Monteiro N, Smith EE, Pagni S,
Zhang W, Khademhosseini A and Yelick PC: GelMA-encapsulated hDPSCs
and HUVECs for dental pulp regeneration. J Dent Res. 96:192–199.
2017.PubMed/NCBI View Article : Google Scholar
|
19
|
Nichol JW, Koshy S, Bae H, Hwang CM,
Yamanlar S and Khademhosseini A: Cell-laden microengineered gelatin
methacrylate hydrogels. Biomaterials. 31:5536–5544. 2010.PubMed/NCBI View Article : Google Scholar
|
20
|
Fan L, Liu C, Chen X, Zou Y, Zhou Z, Lin
C, Tan G, Zhou L, Ning C and Wang Q: Directing induced pluripotent
stem cell derived neural stem cell fate with a three-dimensional
biomimetic hydrogel for spinal cord injury repair. ACS Appl Mater
Interfaces. 10:17742–17755. 2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Zhou P, Xu P, Guan J, Zhang C, Chang J,
Yang F, Xiao H, Sun H, Zhang Z, Wang M, et al: Promoting 3D
neuronal differentiation in hydrogel for spinal cord regeneration.
Colloids Surf B Biointerfaces. 194(111214)2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Shi GD, Cheng X, Zhou XH, Fan BY, Ren YM,
Lin W, Zhang XL, Liu S, Hao Y, Wei ZJ and Feng SQ: iTRAQ-based
proteomics profiling of Schwann cells before and after peripheral
nerve injury. Iran J Basic Med Sci. 21:832–841. 2018.PubMed/NCBI View Article : Google Scholar
|
23
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995.PubMed/NCBI View Article : Google Scholar
|
24
|
Duan HQ, Wu QL, Yao X, Fan BY, Shi HY,
Zhao CX, Zhang Y, Li B, Sun C, Kong XH, et al: Nafamostat mesilate
attenuates inflammation and apoptosis and promotes locomotor
recovery after spinal cord injury. CNS Neurosci Ther. 24:429–438.
2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Zhou XH, Lin W, Ren YM, Liu S, Fan BY, Wei
ZJ, Shi GD, Cheng X, Hao Y and Feng SQ: Comparison of DNA
methylation in Schwann cells before and after peripheral nerve
injury in rats. Biomed Res Int. 2017(5393268)2017.PubMed/NCBI View Article : Google Scholar
|
26
|
Marcol W, Ślusarczyk W, Larysz-Brysz M,
Francuz T, Jędrzejowska-Szypułka H, Łabuzek K and Lewin-Kowalik J:
Grafted activated Schwann cells support survival of injured rat
spinal cord white matter. World Neurosurg. 84:511–519.
2015.PubMed/NCBI View Article : Google Scholar
|
27
|
Katoh H, Yokota K and Fehlings MG:
Regeneration of spinal cord connectivity through stem cell
transplantation and biomaterial scaffolds. Front Cell Neurosci.
13(248)2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Malikmammadov E, Tanir TE, Kiziltay A,
Hasirci V and Hasirci N: PCL and PCL-based materials in biomedical
applications. J Biomater Sci Polym Ed. 29:863–893. 2018.PubMed/NCBI View Article : Google Scholar
|
29
|
Xiao S, Zhao T, Wang J, Wang C, Du J, Ying
L, Lin J, Zhang C, Hu W, Wang L and Xu K: Gelatin methacrylate
(GelMA)-based hydrogels for cell transplantation: An effective
strategy for tissue engineering. Stem Cell Rev Rep. 15:664–679.
2019.PubMed/NCBI View Article : Google Scholar
|
30
|
Li GL, Farooque M and Olsson Y: Changes of
Fas and Fas ligand immunoreactivity after compression trauma to rat
spinal cord. Acta Neuropathol. 100:75–81. 2000.PubMed/NCBI View Article : Google Scholar
|
31
|
Park E, Liu Y and Fehlings MG: Changes in
glial cell white matter AMPA receptor expression after spinal cord
injury and relationship to apoptotic cell death. Exp Neurol.
182:35–48. 2003.PubMed/NCBI View Article : Google Scholar
|
32
|
Chen DF and Tonegawa S: Why do mature CNS
neurons of mammals fail to re-establish connections following
injury-functions of bcl-2. Cell Death Differ. 5:816–822.
1998.PubMed/NCBI View Article : Google Scholar
|
33
|
Wang C, Zhang L, Ndong JC, Hettinghouse A,
Sun G, Chen C, Zhang C, Liu R and Liu CJ: Progranulin deficiency
exacerbates spinal cord injury by promoting neuroinflammation and
cell apoptosis in mice. J Neuroinflammation. 16(238)2019.PubMed/NCBI View Article : Google Scholar
|
34
|
Crown ED, Gwak YS, Ye Z, Johnson KM and
Hulsebosch CE: Activation of p38 MAP kinase is involved in central
neuropathic pain following spinal cord injury. Exp Neurol.
213:257–267. 2008.PubMed/NCBI View Article : Google Scholar
|
35
|
Kasuya Y, Umezawa H and Hatano M:
Stress-activated protein kinases in spinal cord injury: Focus on
roles of p38. Int J Mol Sci. 19(867)2018.PubMed/NCBI View Article : Google Scholar
|
36
|
Zhan J, He J, Chen M, Luo D and Lin D:
Fasudil promotes BMSC migration via activating the MAPK signaling
pathway and application in a model of spinal cord injury. Stem
Cells Int. 2018(9793845)2018.PubMed/NCBI View Article : Google Scholar
|
37
|
Chen NN, Wei F, Wang L, Cui S, Wan Y and
Liu S: Tumor necrosis factor alpha induces neural stem cell
apoptosis through activating p38 MAPK pathway. Neurochem Res.
41:3052–3062. 2016.PubMed/NCBI View Article : Google Scholar
|
38
|
Qian Z, Chang J, Jiang F, Ge D, Yang L, Li
Y, Chen H and Cao X: Excess administration of miR-340-5p
ameliorates spinal cord injury-induced neuroinflammation and
apoptosis by modulating the P38-MAPK signaling pathway. Brain Behav
Immun. 87:531–542. 2020.PubMed/NCBI View Article : Google Scholar
|
39
|
Zhu J, Yu W, Liu B, Wang Y, Shao J, Wang
J, Xia K, Liang C, Fang W, Zhou C and Tao H: Escin induces
caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK
signalling pathway in human osteosarcoma cells in vitro and in
vivo. Cell Death Dis. 8(e3113)2017.PubMed/NCBI View Article : Google Scholar
|